BALLARD PARTNERS

Lobbying for 23ANDME RESEARCH INSTITUTE · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · $10,000.00 income · posted Jul 14, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Government grants, FDA classification, and NIH genomics policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem